Specifically, high levels of circulating TGF-β1 in the peripheral blood of HCC patients can disturb the balance between CD96, CD226, and T cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motifdomain levels in NK cells, which causes NK cell dysfunction. This evidence concerns the gene TGFB1 and hepatocellular carcinoma.